Candidiasis
📧 Sign up to get email alerts when something new happens for Candidiasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-05-30FDA Approved: NYSTATIN — Original Application (Leading Pharma, LLC)
FDA approved Leading Pharma, LLC's Original Application (ANDA208838) to market a generic nystatin product (Nystatin). This represents the fi…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Candida Host Defense Response After Septic Shock in the Critically Ill
This ClinicalTrials.gov entry reports the completion of a study evaluating the Candida host defense response in critically ill patients foll…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Caspofungin for the Treatment of Non-blood Candida Infections (0991-045) [Phase 2]
Completed Phase 2 trial evaluating caspofungin for the treatment of non-blood Candida infections, sponsored by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) [Phase 2]
A completed Phase 2 clinical trial sponsored by Merck Sharp & Dohme LLC investigating pediatric patients with documented Candida (Candidiasi…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058) [Phase 2]
Completed Phase 2 pharmacokinetic study of caspofungin in neonates and infants to evaluate dosing in candidiasis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Immunological Interaction Between the Host and Candida Albicans Biofilm
A completed clinical trial investigating the immunological interaction between the host and Candida albicans biofilms.
-
FDA approval · 2016-10-24FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's Nystatin and Triamcinolone Acetonide as an Original Application (ANDA) for a topical combination product indicated f…
-
FDA approval · 2016-09-26FDA Approved: ITRACONAZOLE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for itraconazole, granting a generic version of the antifungal medication. Th…
-
FDA approval · 2016-05-24FDA Approved: VORICONAZOLE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' generic voriconazole through an Original Application (ANDA); the product is indicated for treating invas…
-
FDA approval · 2016-04-13FDA Approved: VORICONAZOLE — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's original-application generic Voriconazole (voriconazole) for its approved antifungal indications.
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers [Phase 1]
A Phase 1 pharmacokinetic study in healthy Korean male volunteers evaluating Lozanoc and Sporanox has completed. Sponsor: Boryung Pharmaceut…
-
FDA approval · 2016-01-07FDA Approved: NYSTATIN — Original Application (Pharmaceutical Associates, Inc.)
FDA approved a generic Nystatin product from Pharmaceutical Associates, Inc. under an original application (ANDA).
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: The Use of Probiotics in Patients With Symptomatic Oral Lichen Planus [NA]
The trial evaluated probiotics for symptomatic oral lichen planus (with Candida infection) and has completed.
-
FDA approval · 2015-10-14FDA Approved: CICLOPIROX — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Ciclopirox from Padagis Israel Pharmaceuticals Ltd, indicating an update to the product's labeli…
-
CLINICAL_TRIALS trial_result · 2015-09-15Clinical Trial Update: Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis [Phase 3]
A Phase 3 trial comparing micafungin to conventional amphotericin B for neonatal candidiasis was terminated, with results posted in 2015. Th…
-
FDA approval · 2015-08-31FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)
FDA approved a supplemental application for Ketoconazole from Thirty Madison Inc under an existing ANDA, signaling an approved modification …
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients [Phase 3]
A Phase 3 pediatric trial of voriconazole for serious Candida infections, including oropharyngeal candidiasis, was terminated; results were …
-
FDA approval · 2015-03-19FDA Approved: FLUCONAZOLE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Fluconazole from Hikma Pharmaceuticals USA Inc., updating the regulatory approval of this pr…
-
FDA approval · 2015-03-14FDA Approved: FLUCONAZOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for fluconazole from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2015-02-27FDA Approved: FLUCONAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for fluconazole from Rising Pharma Holdings, Inc. for a generic fluconazole product.
-
FDA approval · 2015-02-03FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) from Roerig, resulting in an update/expansion of the product's labeling.
-
FDA approval · 2015-01-05FDA Approved: CLOTRIMAZOLE — Supplemental Application (Rite Aid Corporation)
FDA approved a supplemental application for clotrimazole submitted by Rite Aid Corporation, indicating an updated/expanded approval for this…
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Caspofungin Study for Fungal Infections in Adults in Critical Care Settings [Phase 3]
Phase 3 trial of caspofungin for candidiasis in adults in critical care settings has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-09-26Clinical Trial Update: Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women [Phase 2]
Phase 2 study evaluating a co-formulated vaginal suppository containing metronidazole and miconazole to prevent vaginal infections in HIV-se…
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Study of Micafungin in Patients With Invasive Candidiasis or Candidemia [Phase 3]
A Phase 3 study of micafungin for invasive candidiasis or candidemia has completed, representing a completed trial update for this antifunga…